Companies: 10,795·Total market cap: $144.5T
Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

GLUENASDAQHealthcare● Active
$16.84
+$0.47(+2.84%)
Market Cap$1.1B
P/E Ratio
52W High$25.77
52W Low$4.12
Overview

Monte Rosa Therapeutics, Inc. (GLUE) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · GLUE · as of Mar 17, 2026

Latest filing snapshot

150
+16+11.94%vs prior year

Monte Rosa Therapeutics, Inc. (GLUE) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
150
Change (1Y)
+16
Growth % (1Y)
+11.94%
Revenue / Employee
$824.5K
Net Income / Employee
$-257.5K
Market Cap
$1.1B

GLUE Employee Count

2021 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-17150+16+11.94%
2025-03-20134+1+0.75%
2024-03-14133+10+8.13%
2023-03-16123+30+32.26%
2022-03-2993

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Ginkgo Bioworks Holdings, Inc.
DNA
Ginkgo Bioworks Holdings, Inc.
834
#2
Arvinas, Inc.
ARVN
Arvinas, Inc.
430
#3
MeiraGTx Holdings plc
MGTX
MeiraGTx Holdings plc
375
#4
Geron Corporation
GERN
Geron Corporation
229
#5
Day One Biopharmaceuticals, Inc.
DAWN
Day One Biopharmaceuticals, Inc.
181
#6
Monte Rosa Therapeutics, Inc.
GLUE
Monte Rosa Therapeutics, Inc.YOU
150
#7
ArriVent BioPharma, Inc. Common Stock
AVBP
ArriVent BioPharma, Inc. Common Stock
52
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · GLUE peer comparison

About GLUE employees

GLUE Employees · Headcount

Monte Rosa Therapeutics, Inc. (GLUE) employee data is sourced from the annual SEC 10-K filing. As of 2025, Monte Rosa Therapeutics, Inc. had 150 full-time employees globally. Full-time employees only. Global consolidated headcount.

Monte Rosa Therapeutics, Inc. employs 150 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $824,480, reflecting the company's operational efficiency.

Monte Rosa Therapeutics, Inc.'s workforce increased by 16 (11.94%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Monte Rosa Therapeutics, Inc.'s revenue per employee of $824,480 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

GLUE Employees · 5 questions

As of the latest SEC 10-K filing (2025), Monte Rosa Therapeutics, Inc. had 150 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Monte Rosa Therapeutics, Inc. employee counthow many employees does Monte Rosa Therapeutics, Inc. haveGLUE total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-17